MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response.
Lekha PanditSharik MustafaIchiro NakashimaToshyuki TakahashiKimhiko KanekoPublished in: Multiple sclerosis journal - experimental, translational and clinical (2018)
Our study highlighted the tendency for stereotypical attacks in MOG-IgG-associated disease, heterogeneity in clinical course among subtypes, subclinical visual impairment and the need for early and sustained immunosuppressive therapy.
Keyphrases